Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Viking Therapeutics, Inc. (VKTX) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Viking Therapeutics, Inc. (VKTX), most recent 12 months reported: revenue $0, net loss $534.8M. Latest balance sheet on file: liquid cash $501.66M. From SEC filings. Others in Pharmaceutical Preparations: UNICYCIVE THERAPEUTICS, INC. · Valion Bio, Inc. · Vera Therapeutics, Inc. · VERU INC. · WHITEHAWK THERAPEUTICS, INC. · XBiotech Inc. · EXICURE, INC. · XENON PHARMACEUTICALS INC.

Stock screener

Watchlist